Autres langues Hanmi Pharm. Co., Ltd.

Actions

A128940

KR7128940004

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 13/05/2024			Varia. 5j.	Varia. 1 janv.
314 000 ^KRW	-1,41%		-0,95%	-10,92%

01/05	Les bénéfices de Hanmi Pharm au premier trimestre augmentent de 27,5 % et les ventes de 11,8 %.	MT
19/03	Hanmi Pharm. Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Invion Partners with Hanlim Pharma for Glioblastoma Treatment	08/05
Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8%	01/05
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Aptose Biosciences Inc. announced that it has received $4 million in funding from Hanmi Pharm. Co., Ltd.	31/01
Aptose Biosciences Inc. announced that it expects to receive $4 million in funding from Hanmi Pharm. Co., Ltd.	25/01
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Allergic Rhinitis Pipeline, Clinical Trials, Key Companies	08/11
Hanmi Pharm's Q3 Income Surges 94%	02/11
Allergic Rhinitis Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)	28/09/23
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib First-in-Class Candidate for the Treatment of Intermediate Dry AMD	26/09/23
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
Aptose Biosciences Inc. announced that it expects to receive $6.999998 million in funding from Hanmi Pharm. Co., Ltd.	10/08/23
Hanmi Pharm's Net Income Declines in Q2	01/08/23
Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).	31/07/23
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Hanmi Pharm's Net Income Climbs in Q1	27/04/23
Assertio Holdings, Inc. (NasdaqCM : ASRT) entered into a definitive agreement to acquire Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI) for approximately $250 million.	25/04/23
Hanmi Pharm. Co., Ltd.'s Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirms Non-inferiority Efficacy and Safety Compared to Monotherapy in The Lancet' & 'European Heart Journal	17/03/23
Advanced Gastric Carcinoma Pipeline Assessment of Active Pipeline Assets Segmented by Stage, Product Type, Route of Administration, and Molecule Type	14/03/23
Hanmi Pharm's Net Income Plunges 23.7% in Q4	09/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hanmi Pharm. Co., Ltd.

Actions

A128940

KR7128940004

Autres langues

Filtres